Advanced search
Publication Cover
Nutrition and Dietary Supplements Volume 4, 2012 - Issue
Submit an article Journal homepage
18
Views
0
CrossRef citations to date
0
Altmetric
Original Research

ProAlgaZyme and its subfractions increase plasma HDL cholesterol via upregulation of ApoA1, ABCA1, and SRB1, and inhibition of CETP in hypercholesterolemic hamsters

Andreea GeamanuNutrition and Food Science, Wayne State University, Detroit, MI, USA
,
Nadia SaadatNutrition and Food Science, Wayne State University, Detroit, MI, USA
,
Arvind GojaNutrition and Food Science, Wayne State University, Detroit, MI, USA
,
Monika WadehraNutrition and Food Science, Wayne State University, Detroit, MI, USA
,
Xiangming JiNutrition and Food Science, Wayne State University, Detroit, MI, USA
&
Smiti V GuptaNutrition and Food Science, Wayne State University, Detroit, MI, USACorrespondence[email protected]
Pages 17-24 | Published online: 20 Jun 2012

References

  • Lin Y, Mousa SS, Elshourbagy N, Mousa SA. Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy. Vasc Health Risk Manag. 2010;6:73–85.
  • Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123:933–944.
  • Duffy D, Rader DJ. Update on strategies to increase HDL quantity and function. Nat Rev Cardiol. 2009;6:455–463.
  • Davidson MH. Focus on HDL as a therapeutic target for CAD risk reduction. Am J Cardiol. 2009;104(10 Suppl):1E–2E.
  • Arsenault BJ, Boekholdt SM, Kastelein JJ. Lipid parameters for measuring risk of cardiovascular disease. Nat Rev Cardiol. Apr 2011; 8(4):197–206.
  • Gordon SM, Hofmann S, Askew DS, Davidson WS. High density lipoprotein: it’s not just about lipid transport anymore. Trends Endocrinol Metab. 2011;22:9–15.
  • Nofer JR, Kehrel B, Fobker M, Levkau B, Assmann G, von Eckardstein A. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis. 2002;161:1–16.
  • Harding SV, Zhao HL, Marinangeli CP, et al. Red algal cellular biomass lowers circulating cholesterol concentrations in Syrian golden hamsters consuming hypercholesterolaemic diets. Br J Nutr. 2009; 102:842–847.
  • Chen J, Jiang Y, Ma KY, Chen F, Chen ZY. Microalga decreases plasma cholesterol by down-regulation of intestinal NPC1 L1, hepatic LDL receptor, and HMG-CoA reductase. J Agric Food Chem. 2011;59:6790–6797.
  • Bocanegra A, Bastida S, Benedi J, Nus M, Sanchez-Montero JM, Sanchez-Muniz FJ. Effect of seaweed and cholesterol-enriched diets on postprandial lipoproteinaemia in rats. Br J Nutr. 2009;102: 1728–1739.
  • Bocanegra A, Bastida S, Benedi J, Rodenas S, Sanchez-Muniz FJ. Characteristics and nutritional and cardiovascular-health properties of seaweeds. J Med Food. 2009;12:236–258.
  • Jimenez-Escrib A S-MF. Dietary fibre from edible seaweeds: chemical structure physicochemical properties and effects on cholesterol metabolism. Nutr Res. 2000;20:585–598.
  • Oben J, Enonchong E, Kuate D, et al. The effects of ProAlgaZyme novel algae infusion on metabolic syndrome and markers of cardiovascular health. Lipids Health Dis. 2007;6:20.
  • Bartley GE, Yokoyama W, Young SA, et al. Hypocholesterolemic effects of hydroxypropyl methylcellulose are mediated by altered gene expression in hepatic bile and cholesterol pathways of male hamsters. J Nutr. 2010;140:1255–1260.
  • Kim HJ, Jeon SM, Lee MK, et al. Comparison of hesperetin and its metabolites for cholesterol-lowering and antioxidative efficacy in hypercholesterolemic hamsters. J Med Food. 2010;13: 808–814.
  • Chapman MJ, Goldstein S, Lagrange D, Laplaud PM. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. J Lipid Res. 1981;22:339–358.
  • Edelstein C, Pfaffinger D, Scanu AM. Advantages and limitations of density gradient ultracentrifugation in the fractionation of human serum lipoproteins: role of salts and sucrose. J Lipid Res. 1984;25:630–637.
  • Izem L, Morton RE. Molecular cloning of hamster lipid transfer inhibitor protein (apolipoprotein F) and regulation of its expression by hyperlipidemia. J Lipid Res. Apr 2009;50(4):676–684.
  • Dorfman SE, Wang S, Vega-Lopez S, Jauhiainen M, Lichtenstein AH. Dietary fatty acids and cholesterol differentially modulate HDL cholesterol metabolism in Golden-Syrian hamsters. J Nutr. Mar 2005; 135(3):492–498.
  • Field FJ, Born E, Mathur SN. Stanol esters decrease plasma cholesterol independently of intestinal ABC sterol transporters and Niemann-Pick C1-like 1 protein gene expression. J Lipid Res. Dec 2004;45(12):2252–2259.
  • Suckling KE, Benson GM, Bond B, et al. Cholesterol lowering and bile acid excretion in the hamster with cholestyramine treatment. Atherosclerosis. 1991;89:183–190.
  • Weingand KW, Daggy BP. Effects of dietary cholesterol and fasting on hamster plasma lipoprotein lipids. Eur J Clin Chem Clin Biochem. 1991;29:425–428.
  • Ryan AS, Keske MA, Hoffman JP, Nelson EB. Clinical overview of algal-docosahexaenoic acid: effects on triglyceride levels and other cardiovascular risk factors. Am JTher. 2009;16:183–192.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.